November 28, 2018
162,808
1,046
110
0.71%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:11Now PlayingTuberculosis research stalled in the late 20th century, because existing drugs were seen as sufficient, and there was little financial incentive to create new ones. In 2005, Dr. Andreas Diacon founded an organization called TASK to help accelerate the development pipeline for novel TB treatments. They’ve overseen trials of multiple drugs that are now being used to cure patients, including some with drug-resistant TB.
Learn more at
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.